About Donna Felsenstein, MD
Departments, Centers, & Programs:
Clinical Interests:
- Herpes simplex virus
- Infectious diseases
- Lyme disease
Treats:
- Adult
Locations
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
Phone: 617-726-3906
Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Infectious Disease, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
- Tucker, JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, Papaliodis GN, Durand ML, Felsenstein, D. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect. 2010.
- Li JZ, Tucker, JD Lobo AM, Marra CM; Davis, BT, Papaliodis GN, Felsenstein D, Durand M, Yawetz S, and Robbins GK. Ocular syphilis among HIV-infected individuals. CID 2010
- Henrich TJ, Li JZ, Felsenstein, D, et al. Xenotropic murine leukemia virus related virus prevalence in patients with Chronic Fatigue Syndrome or Chronic Immunomodualtory Conditions. JID, 2010.
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2025-2026.

Reviews: Comments and Ratings